Riley Michael J, Marrouche Nassir F
Division of Cardiology, University of Utah Health Sciences Center, Salt Lake City 84132-2400, USA.
Curr Probl Cardiol. 2006 May;31(5):361-90. doi: 10.1016/j.cpcardiol.2006.01.002.
Due in large part to the growing dissatisfaction with traditional pharmacologic approaches to atrial fibrillation (AF) management, and fueled by both the fruits of basic and clinical investigation into the nature of AF initiation and maintenance and the explosive development in catheter-based technologies, AF ablation has matured from a purely investigational technique to a viable--and often preferred--strategy for treating patients suffering from this arrhythmia. Future insights and developments will help us refine our treatment strategies, making AF ablation safer, faster, and more effective. As the prevalence of AF in the general population continues to expand, the goal of optimizing our approach to AF becomes ever more important--and more pressing.
在很大程度上,由于对心房颤动(AF)传统药物治疗方法的不满日益增加,同时受到对AF发生和维持机制的基础及临床研究成果以及基于导管技术的迅猛发展的推动,AF消融已从一种纯粹的研究性技术发展成为治疗这种心律失常患者的可行且往往更受青睐的策略。未来的见解和发展将帮助我们完善治疗策略,使AF消融更安全、更快速且更有效。随着普通人群中AF患病率持续上升,优化我们对AF的治疗方法这一目标变得愈发重要且紧迫。